• Bifendate in Acute Liver Injury: Multiomics Evidence

  2026-10-06

  Talifu et al. used co-expression networks, transcriptomics, and proteomics to compare how bifendate and muaddil sapra affect molecular modules in a preclinical acute liver injury model. The study supports a systems-level view of DDB-associated responses, while its model and association-based analyses limit direct conclusions about human efficacy or clinical mechanism.

• HOBt in Medicinal Chemistry: Evidence and Limits

  2026-10-05

  A source-grounded overview of HOBt in amide bond formation, using a glucagon receptor antagonist study to distinguish reagent utility from downstream biological evidence, while examining peptide synthesis applications, evidence strength, and research limitations.

• Cy5 Amine (Non-Sulfonated): Product Overview

  2026-10-05

  Cy5 amine (non-sulfonated), SKU A8143, is a supplier-described amine-functionalized cyanine dye for research labeling applications. No matched paper evidence was provided, so its stated specifications and application scope should not be treated as independently validated performance.

• HOBt in Peptide Coupling: Evidence and Limits

  2026-10-03

  HOBt is widely associated with amide bond formation and minimizing epimerization in peptides. This overview examines its conceptual chemistry context, its documented use in a 2015 glucagon receptor antagonist study, and the limits of inferring reagent performance from medicinal-chemistry outcomes.

• Mianserin HCl: 5-HT2 Assay Workflows

  2026-10-02

  Mianserin HCl supports controlled studies of 5-HT2 receptor signaling, neuronal phenotypes, cyclodextrin-enabled cytotoxicity, and antipathogenic activity. This practical guide connects the compound’s receptor pharmacology with reproducible dosing, assay design, and troubleshooting strategies.

• 3-Deazaadenosine for Methylation & Viral Models

  2026-10-01

  3-Deazaadenosine is a mechanistically useful S-adenosylhomocysteine hydrolase inhibitor for separating methylation-dependent effects from gene-specific perturbations. This workflow-focused guide covers inflammatory cell models, preclinical antiviral research, formulation, assay design, and troubleshooting.

• Propranolol Research Workflows and Troubleshooting

  2026-10-01

  Build reproducible Propranolol experiments spanning cardiovascular regulation, emotional memory modulation, essential tremor research, and metabolic assays. This guide combines formulation controls, functional endpoints, dose-screening logic, and troubleshooting for a non-selective β-adrenergic receptor blocker.

• DDM for Dynamic Membrane Protein Structures

  2026-09-30

  Explore how n-Dodecyl-β-D-maltoside (DDM) can support membrane protein structural studies without disguising conformational heterogeneity. This guide connects detergent chemistry with recent full-length αvβ3 integrin cryo-EM findings and practical assay design.

• Transcription Condensates and Genome Stability

  2026-09-30

  Marmolejo et al. identify a cell-cycle timer that forms transcription condensates at histone locus bodies during the G1/S transition and removes them in mid-S phase through ATR-CHK1 signaling. The study connects condensate resolution with linker histone H1.1 control and genome protection, offering a mechanistic framework for understanding replication-transcription coordination.

• 3X FLAG Peptide for Mechanistic Assays

  2026-09-29

  The 3X (DYKDDDDK) Peptide is more than a high-sensitivity epitope reagent: it can help separate protein abundance, interaction, and degradation in mechanistic assays. This guide develops an assay-design framework around STAT2–NS5 biology, metal sensitivity, purification, and structural workflows.

• HOBt (1-Hydroxybenzotriazole) in Reliable Workflows

  2026-09-29

  This scenario-based guide explains how HOBt (1-Hydroxybenzotriazole), SKU A7025, supports controlled amide bond formation and helps protect stereochemical integrity before compounds enter cell viability or cytotoxicity assays. It separates upstream synthesis benefits from assay-specific validation, with practical storage, solubility, optimization, and vendor-selection guidance.

• KIR2.1 Inhibition in Pulmonary Vascular Remodeling

  2026-09-28

  The reference study identifies KIR2.1 as a regulator of pulmonary artery smooth muscle cell proliferation and migration through the TGF-β1/SMAD2/3 pathway. Using a monocrotaline pulmonary hypertension model and PDGF-BB-stimulated human cells, the authors show that pharmacological KIR2.1 inhibition suppresses remodeling-associated phenotypes and reduces OPN and PCNA expression.

• Troglitazone: PPARγ Agonist Research Guide

  2026-09-28

  Troglitazone is a PPARγ agonist used in research on nuclear-receptor signaling and lipid and glucose metabolism. Product information also describes renal-carcinoma cell findings, but the cited SPP1 tumor-macrophage study does not establish troglitazone as an SPP1 modulator.

• Veratridine Workflows for Sodium Channel Research

  2026-09-27

  Use Veratridine to drive controlled sodium-channel activation in neuronal excitotoxicity experiments and functional blocker screens. This guide separates a literature-based cortical-culture workflow from practical assay recommendations—and explains why channel activation does not guarantee neuroprotection when a blocker is added.

• 3X (DYKDDDDK) Peptide in CDK4 Assays

  2026-09-26

  A practical guide to using the 3X (DYKDDDDK) Peptide for competitive elution and specificity controls when studying CDK4–4E-BP1 signaling. It connects the reference study’s phosphorylation findings to recombinant-protein workflows while distinguishing the free peptide from a FLAG-tagged construct.

7941 records 1/530 page Next 12345 下5页 Last page